Your browser doesn't support javascript.
loading
The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.
Johansson, Mattias; Carreras-Torres, Robert; Scelo, Ghislaine; Purdue, Mark P; Mariosa, Daniela; Muller, David C; Timpson, Nicolas J; Haycock, Philip C; Brown, Kevin M; Wang, Zhaoming; Ye, Yuanqing; Hofmann, Jonathan N; Foll, Matthieu; Gaborieau, Valerie; Machiela, Mitchell J; Colli, Leandro M; Li, Peng; Garnier, Jean-Guillaume; Blanche, Helene; Boland, Anne; Burdette, Laurie; Prokhortchouk, Egor; Skryabin, Konstantin G; Yeager, Meredith; Radojevic-Skodric, Sanja; Ognjanovic, Simona; Foretova, Lenka; Holcatova, Ivana; Janout, Vladimir; Mates, Dana; Mukeriya, Anush; Rascu, Stefan; Zaridze, David; Bencko, Vladimir; Cybulski, Cezary; Fabianova, Eleonora; Jinga, Viorel; Lissowska, Jolanta; Lubinski, Jan; Navratilova, Marie; Rudnai, Peter; Benhamou, Simone; Cancel-Tassin, Geraldine; Cussenot, Olivier; Weiderpass, Elisabete; Ljungberg, Börje; Tumkur Sitaram, Raviprakash; Häggström, Christel; Bruinsma, Fiona; Jordan, Susan J.
Affiliation
  • Johansson M; International Agency for Research on Cancer (IARC), Lyon, France.
  • Carreras-Torres R; International Agency for Research on Cancer (IARC), Lyon, France.
  • Scelo G; International Agency for Research on Cancer (IARC), Lyon, France.
  • Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Mariosa D; International Agency for Research on Cancer (IARC), Lyon, France.
  • Muller DC; Imperial College, London, United Kingdom.
  • Timpson NJ; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Haycock PC; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Brown KM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Wang Z; St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  • Ye Y; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Foll M; International Agency for Research on Cancer (IARC), Lyon, France.
  • Gaborieau V; International Agency for Research on Cancer (IARC), Lyon, France.
  • Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Colli LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Li P; International Agency for Research on Cancer (IARC), Lyon, France.
  • Garnier JG; Max Planck Institute for Demographic Research, Rostock, Germany.
  • Blanche H; Centre National de Genotypage, Institut de Genomique, Centre de l'Energie Atomique et aux Energies Alternatives, Evry, France.
  • Boland A; Fondation Jean Dausset - Centre d'Etude du Polymorphisme Humain, Paris, France.
  • Burdette L; Fondation Jean Dausset - Centre d'Etude du Polymorphisme Humain, Paris, France.
  • Prokhortchouk E; Centre National de Genotypage, Institut de Genomique, Centre de l'Energie Atomique et aux Energies Alternatives, Evry, France.
  • Skryabin KG; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Yeager M; Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow, Russian Federation.
  • Radojevic-Skodric S; Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow, Russian Federation.
  • Ognjanovic S; Kurchatov Scientific Center, Moscow, Russian Federation.
  • Foretova L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
  • Holcatova I; Institute of Pathology, Medical School of Belgrade, Belgrade, Serbia.
  • Janout V; Clinic of Urology, Clinical Center of Serbia, Belgrade, Serbia.
  • Mates D; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, United States of America.
  • Mukeriya A; International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.
  • Rascu S; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Zaridze D; Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Bencko V; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
  • Cybulski C; National Institute of Public Health, Bucharest, Romania.
  • Fabianova E; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
  • Jinga V; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
  • Lissowska J; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
  • Lubinski J; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Navratilova M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Rudnai P; Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.
  • Benhamou S; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
  • Cancel-Tassin G; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Cussenot O; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Weiderpass E; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Ljungberg B; National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary.
  • Tumkur Sitaram R; INSERM U946, Paris, France.
  • Häggström C; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
  • Bruinsma F; CeRePP, Paris, France.
  • Jordan SJ; UPMC Univ Paris 06, GRC n°5, Institut Universitaire de Cancérologie, Paris, France.
PLoS Med ; 16(1): e1002724, 2019 01.
Article in En | MEDLINE | ID: mdl-30605491
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Obesity Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2019 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Obesity Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2019 Type: Article Affiliation country: France